mRNA-based COVID-19 Vaccines Booster Dose: Benefits, Risks, and Coverage

The number of COVID-19 vaccine-rich countries that have started COVID-19 third-dose booster programs is growing dramatically despite the lack of robust evidence on the effectiveness, safety, and frequency of the required booster doses that make the individuals/populations immune to COVID-19 infectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Nashwan, Abdulqadir J., Yassin, Mohamed A., Soliman, Ashraf T., De Sanctis, Vincenzo, Ibrahim, Mohamed I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335425/
https://www.ncbi.nlm.nih.gov/pubmed/35775753
http://dx.doi.org/10.23750/abm.v93i3.13103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335425/
https://www.ncbi.nlm.nih.gov/pubmed/35775753
http://dx.doi.org/10.23750/abm.v93i3.13103

Ejemplares similares